MR
Marizyme, Inc.
MRZM · OTC
$0.00 +0.00% (+$0.00)
Market Cap $39.5K
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.06x
PEG N/A
P/E N/A
Growth
100 /100
Growing Rev. growth 48.52%
Book val. growth N/A
EPS growth N/A
Profitability
14 /100
Weak Op. margin 5,278.10%
Gross margin 36.99%
FCF margin 725.42%
Quality
0 /100
Poor Asset turnover 0.03x
ROIC 186.37%
ROA 315.87%
Debt
0 /100
High Int. coverage -1.86x
Current ratio 0.04x
Debt/Assets N/A
Stability
26 /100
Unstable EPS volatility 88.08%
Beta 0.86x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MRZM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David L. Barthel
Employees
13
Headquarters
Jupiter